Zions Bancorporation National Association UT Increases Stock Position in Integer Holdings Corporation $ITGR

Zions Bancorporation National Association UT increased its holdings in Integer Holdings Corporation (NYSE:ITGR) by 3.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,430 shares of the medical equipment provider’s stock after buying an additional 1,098 shares during the period. Zions Bancorporation National Association UT owned 0.10% of Integer worth $4,234,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Emerald Advisers LLC grew its stake in Integer by 1,542.0% during the second quarter. Emerald Advisers LLC now owns 103,824 shares of the medical equipment provider’s stock valued at $12,767,000 after acquiring an additional 97,501 shares in the last quarter. Intech Investment Management LLC lifted its stake in Integer by 92.8% in the 1st quarter. Intech Investment Management LLC now owns 22,682 shares of the medical equipment provider’s stock worth $2,677,000 after purchasing an additional 10,915 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Integer in the 1st quarter valued at $916,000. Wakefield Asset Management LLLP purchased a new position in shares of Integer during the 2nd quarter valued at $1,118,000. Finally, Russell Investments Group Ltd. increased its holdings in shares of Integer by 14.7% in the first quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider’s stock worth $796,000 after purchasing an additional 863 shares during the period. Institutional investors own 99.29% of the company’s stock.

Insider Buying and Selling at Integer

In other Integer news, CEO Payman Khales bought 3,127 shares of the business’s stock in a transaction that occurred on Thursday, October 30th. The shares were bought at an average cost of $64.94 per share, with a total value of $203,067.38. Following the completion of the purchase, the chief executive officer directly owned 22,865 shares of the company’s stock, valued at $1,484,853.10. This trade represents a 15.84% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 2.16% of the company’s stock.

Integer Stock Up 2.4%

Shares of Integer stock opened at $68.24 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $146.36. The company’s 50 day moving average price is $95.47 and its 200-day moving average price is $108.98. The stock has a market capitalization of $2.39 billion, a price-to-earnings ratio of 28.55, a P/E/G ratio of 0.60 and a beta of 0.95.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a net margin of 4.75% and a return on equity of 12.84%. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Equities research analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its board has authorized a stock repurchase program on Tuesday, November 4th that allows the company to repurchase $200.00 million in shares. This repurchase authorization allows the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ITGR shares. Benchmark reissued a “hold” rating on shares of Integer in a research note on Friday, October 24th. Piper Sandler lowered their price target on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a report on Friday, October 24th. Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a report on Saturday, October 25th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Integer in a research note on Friday, October 31st. Finally, Citigroup dropped their target price on shares of Integer from $77.00 to $69.00 and set a “neutral” rating for the company in a research report on Monday, November 3rd. Four equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $96.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.